A meta-analysis of six large observational studies of women with BRCA1/2-mutations (n=6135) demonstrates an undeniable slashing of not only breast cancer-specific mortality (OR 0.19) but also overall mortality (HR 0.37) with bilateral prophylactic mastectomy. | O’Reilly, JAMA Surg 2026
